About Auxilium Biotechnologies
Auxilium Biotechnologies is a private company based in San Diego, California. It has reported $7,186,003 raised in two offerings on Form D since January 2020. Its chief executive is Yacov Koffler.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 18, 2025 | Oct 23, 2025amended Dec 11, 2025 | $3,936,015of $10.0M target | 16 | $246K | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jan 10, 2020 | Jan 21, 2020 | $3,249,988of $3.9M target | 18 | $180K | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $7,186,003 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Auxilium Biotechnologies's Form D filed Dec 11, 2025.
YK
Yacov Koffler
Chief Executive Officer and director
CA
Craig Andrews
Director
MT
Mark Tuszynski
Director
RE
Robert Engler
Director
Earlier filings also listed Donald Cohn (director, last listed Jan 2020).